MedPage Today  Jul 21  Comment 
(MedPage Today) -- News and commentary from the endocrinology world
FiercePharma  Jul 20  Comment 
Sanofi’s top-selling Lantus is already contending with one copycat rival, and Merck & Co. just won FDA approval for another. Luckily for the $5 billion basal insulin, Merck’s new Lusduna Nexvue has to sit on the sidelines for now—and maybe...
FierceBiotech  Jul 20  Comment 
Belgian biotech Ablynx just signed a potentially lucrative new deal with Sanofi that could be worth an eye-watering €2.4 billion, although just €23 million of that comes up front.
FiercePharma  Jul 18  Comment 
It's the heat of the summer, when few are thinking about the coming influenza threat. But top vaccine manufacturers have already kicked off their flu shot shipments as AstraZeneca stands to lose out on yet another season of sales.
FiercePharma  Jul 18  Comment 
Emergent BioSolutions is about to add the only FDA-approved smallpox vaccine to its portfolio through a $125 million deal with Sanofi Pasteur.
FiercePharma  Jul 14  Comment 
​​​​​​​After taking a beating in countless press reports over its Zika vaccine partnership with the U.S. Army, Sanofi is hoping to clear the air with a flurry of letters to critical U.S. senators.
FiercePharma  Jul 14  Comment 
The road to blockbuster land is steeper and rougher than it used to be, and payer footprints are all over it. Consider the much-anticipated Dupixent. Even with early coverage secured with upfront negotiations, obstacles are hampering its path to...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki